Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasm Metastasis 12Pain 10Bone Neoplasms 8Breast Neoplasms 6Humoral Hypercalcemia Of Malignancy 2Prostatic Neoplasms 1Osteoporosis 1Multiple Myeloma 1Lung Neoplasms 1Hematologic Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Renal Cell 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 5parathyroid hormone-related peptide (1-36) 2Ibandronic Acid 2Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Denosumab 1Antibodies, Monoclonal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Humoral Hypercalcemia Of Malignancy × Ibandronic Acid × Clear all
NCT00301886 2013-11-13

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

SWOG Cancer Research Network

Phase 3 Withdrawn
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain

NCT00326820 2013-03-13

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

Wales Cancer Trials Unit

Phase 3 Unknown
1,404 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡